Successful treatment of disseminated Verruconis gallopava infection in a heart transplant recipient: A case report.
Am J Health Syst Pharm
; 79(13): 1066-1069, 2022 06 23.
Article
in English
| MEDLINE | ID: covidwho-1730640
ABSTRACT
PURPOSE:
To describe a case of disseminated Verruconis gallopava infection in a cardiac transplant recipient that was successfully treated with oral posaconazole and intravenous anidulafungin.SUMMARY:
A 51-year-old male initially presented with pulmonary manifestations, but subsequently developed cutaneous lesions, fungemia, osteomyelitis of the hip requiring excision, and eventually brain abscesses over the course of 3 months. The patient was successfully treated with various antifungal agents throughout his treatment course and was eventually discharged on oral posaconazole and intravenous anidulafungin. He remained on oral posaconazole suppressive therapy and had had no recurrence of fungal infection after 31 months of follow-up.CONCLUSION:
On the basis of this case report, intravenous anidulafungin and chronic suppressive therapy with oral posaconazole can successfully treat disseminated V. gallopava infections.Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Ascomycota
/
Heart Transplantation
/
Mycoses
Type of study:
Case report
/
Cohort study
/
Prognostic study
Limits:
Humans
/
Male
/
Middle aged
Language:
English
Journal:
Am J Health Syst Pharm
Journal subject:
Pharmacy
/
Hospitals
Year:
2022
Document Type:
Article
Affiliation country:
Ajhp
Similar
MEDLINE
...
LILACS
LIS